Tumor p53 status and response to topoisomerase II inhibitors.
about
Comparative analysis of xanafide cytotoxicity in breast cancer cell lines.Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer.Metnase mediates chromosome decatenation in acute leukemia cells.Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis.QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells.A proteomic approach to identifying new drug targets (potentiating topoisomerase II poisons).
P2860
Tumor p53 status and response to topoisomerase II inhibitors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumor p53 status and response to topoisomerase II inhibitors.
@ast
Tumor p53 status and response to topoisomerase II inhibitors.
@en
type
label
Tumor p53 status and response to topoisomerase II inhibitors.
@ast
Tumor p53 status and response to topoisomerase II inhibitors.
@en
prefLabel
Tumor p53 status and response to topoisomerase II inhibitors.
@ast
Tumor p53 status and response to topoisomerase II inhibitors.
@en
P1476
Tumor p53 status and response to topoisomerase II inhibitors.
@en
P2093
Daniel M Sullivan
Nikola I Valkov
P356
10.1016/S1368-7646(02)00143-7
P577
2003-02-01T00:00:00Z